Emerging Opportunities in Controlled-Release Generic Drugs

The global generics market is estimated at about $225 billion in 2011. By 2016, it is expected that the value of the total global generics sector will have risen to $358 billion, representing more t...

The global market for controlled-release barrier materials will approach $1 billion by 2015, increasing from nearly $600 million in 2010, a compound annual growth rate (CAGR) of 10.5% for all products wo...

GBI Research's report, ”, provides the key data and analyzes the major challenges and drivers for the...

This new report provides a complete review of the emerging opportunities and operating environment for inhalation and nasal spray drugs. It reviews products currently available generically and assesses the prospects for those drugs losing p...

This market leading strategic analysis from Espicom provides the market context for injectable generic drugs, individual analysis of 55 leading therapies and evaluation of 19 companies active in the sector. Key therapy sectors include cance...

IntroductionThe emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing s...

This important new strategic report from Espicom evaluates the CNS generic drug market and provides detailed assessment and forecast for leading products by value to 2012, patent expiry opportunities to 2015 and competitive evaluation. ...

Cardiovascular Generic Drugs:Prospects & Opportunities to 2012Providing…Detailed assessment and forecast for leading products by value to 2012An assessment of pat...